VariantPulseEvidence monitor liveADr. A. Kassim, open settings
VariantPulseRegional evidence
Compare global genomic interpretation with evidence relevant to Arab and Gulf populations. Where the two disagree, VariantPulse surfaces the disagreement rather than picking a winner.
Global
ClinVar submissions, reference population frequencies and published international evidence. The reference cohorts behind these datasets are predominantly of European ancestry.
12 variants read live from ClinVar
Regional
Observations from Arab and Gulf cohorts, where founder effects and higher consanguinity can make a variant behave differently from the global reference set.
8 variants held · Arab and Gulf population evidence
Cohort counts and assertions are modelled for this workspace. Cited literature is real and is provided as supporting context. VariantPulse does not imply endorsement by, or integration with, any national programme or registry.
2
Conflicting interpretations
Global and regional readings differ
6
Consistent interpretations
Both sources agree on the band
135
Regional observations
Across the variants held in the index
Human review required. VariantPulse does not rank one source above the other.
Global
Read from ClinVar, which aggregates submissions dominated by European-ancestry cohorts.
Regional
Modelled regional aggregation maintained inside this workspace.
VariantPulse analysis
One source places this variant in the clinically actionable band and the other does not. Observed in nine regional probands with a consistent neonatal hyperekplexia phenotype, several from consanguineous families where the change segregated with disease. Published work reports that GLRA1 genotype in hyperekplexia tracks with ethnicity, which is the mechanism by which a globally benign reading and a regional pathogenic reading can both be internally consistent.
VariantPulse recommends manual review due to conflicting interpretation across evidence sources. It does not rank one source above the other.
Global
Read from ClinVar, which aggregates submissions dominated by European-ancestry cohorts.
Regional
Modelled regional aggregation maintained inside this workspace.
VariantPulse analysis
One source places this variant in the clinically actionable band and the other does not. Enriched in regional familial hypercholesterolaemia cohorts relative to the global reference set, with a splice-impact signal reported in affected families. The mutation spectrum of familial hypercholesterolaemia across Arab countries is documented as distinct from European cohorts, so a benign reading derived largely from European data does not settle the question here.
VariantPulse recommends manual review due to conflicting interpretation across evidence sources. It does not rank one source above the other.
Variants where the regional index agrees with the global consensus.
| Variant | Global | Regional | Observations | Cohort |
|---|---|---|---|---|
| BRCA1c.5522G>T | Likely pathogenic | Pathogenic | 3 | 5,400 |
| TP53c.440T>G | Pathogenic | Pathogenic | 2 | 5,400 |
| SCN5Ac.3287A>G | Likely benign | Likely benign | 11 | 3,900 |
| MSH2c.1006C>G | Conflicting | VUS | 4 | 5,400 |
| PALB2c.682C>T | Pathogenic | Pathogenic | 5 | 5,400 |
| APCc.4399C>T | Benign | Benign | 87 | 5,400 |
A variant that is common and harmless in one population can be a founder variant in another. When the reference data behind a classification does not include the population a patient belongs to, a confident global reading can still be the wrong reading locally. VariantPulse holds both and asks a clinician to weigh them, rather than resolving the disagreement automatically.